Skip to content
The African Exponent DATA
Resources

Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text; matched to OCR text and compared cell by cell with the page image; read from the page image) (9 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review

Vitafoam

VITAFOAM · Nigerian Exchange · Consolidated statements

On this page
Company details
Legal name
Vitafoam Nigeria Plc
Listing
VITAFOAM on the Nigerian Exchange, active · ISIN NGVITAFOAM00 (observed 2026-10-08)
Sector
Not classified (our classification from the stated principal activity)
Financial year ends
30 September

Overview

Year ended 30 September 2025 · audited financial statements, signed / final · source

  • Revenue

    NGN 111 billion

    111,379,338 NGN thousands · p56

    +34.8% vs 2024

  • Operating profit / (loss)

    NGN 27.3 billion

    27,280,091 NGN thousands · p56

    +286.9% vs 2024

  • Profit / (loss) for the year

    NGN 14.5 billion

    14,537,221 NGN thousands · p56

    +1426.7% vs 2024

  • Total assets

    NGN 65.3 billion

    65,275,389 NGN thousands · p57

    +25.0% vs 2024

  • Total equity

    NGN 35.6 billion

    35,554,461 NGN thousands · p57

    +42.0% vs 2024

  • Cash from operations

    NGN 15.2 billion

    15,230,052 NGN thousands · p60

    +361.9% vs 2024

Large amounts are rounded for reading (NGN million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.

Financial statements

Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in NGN thousands unless the row says otherwise; brackets are negative.

† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table

Column sources

  • FY to 30 Sep 2025 — audited financial statements, signed / final; reported for the year · source
  • FY to 30 Sep 2024 — audited financial statements, signed / final; comparative in the FY to 30 Sep 2025 filing · source

Income statement

Income statement, NGN thousands. Columns: FY to 30 Sep 2025 — audited financial statements (signed / final), as reported for the year; FY to 30 Sep 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 30 Sep 2025Audited financial statementsreported for the yearFY to 30 Sep 2024Audited financial statementscomparative in FY to 30 Sep 2025 filing
Revenue 111,379,338 82,639,888
Cost of sales (70,422,750) (52,333,877)
Gross profit 40,956,588 30,306,011
Other gains/(losses)1 773,987 (12,120,325)
Distribution expenses (4,082,909) (2,887,785)
Movement in expected credit loss allowances 52,437 (69,745)
Administrative expenses (10,420,012) (8,176,455)
Operating Profit 27,280,091 7,051,701
Finance income 10,910 866,562
Finance costs (5,810,529) (6,772,939)
Profit/(loss) before taxation 21,480,472 1,145,324
Taxation (6,943,251) (193,134)
Profit/(loss) for the year 14,537,221 952,190
Other comprehensive (loss)/income for the year net of taxation (2,355,033) 8,865,637
Total comprehensive income for the year 12,182,188 9,817,827
Non-controlling interest2 1,025,841 592,486
Notes and alternative reported figures (2)
  1. “Other gains/(losses)” is an issuer-specific line, not mapped to a shared definition: Note 8: printed as one line within operating profit.
  2. “Non-controlling interest” is an issuer-specific line, not mapped to a shared definition: Attribution of profit.

Balance sheet

Balance sheet, NGN thousands. Columns: FY to 30 Sep 2025 — audited financial statements (signed / final), as reported for the year; FY to 30 Sep 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 30 Sep 2025Audited financial statementsreported for the yearFY to 30 Sep 2024Audited financial statementscomparative in FY to 30 Sep 2025 filing
Property, plant and equipment 15,914,443 15,937,112
Intangible assets 42,815 124,654
Investment property –1 –1
Investments in subsidiaries2 –1 –1
Right-of-use assets 176,747 183,892
Investment in financial assets3 21,631 17,450
Finance lease receivables4 121,141 86,352
Deferred tax 899,287 862,485
Non-current assets (unlabelled subtotal) 17,176,064 17,211,945
Inventories 28,734,447 20,543,078
Trade and other receivables 4,298,889 4,089,713
Other assets 6,048,934 3,255,858
Cash and cash equivalents (excluding bank overdraft) 9,017,055 7,110,133
Current assets (unlabelled subtotal) 48,099,325 34,998,782
Total Assets 65,275,389 52,210,727
Share capital 625,422 625,422
Reserves5 6,918,121 8,871,013
Retained earnings 25,869,820 14,073,967
Equity attributable to owners (unlabelled subtotal) 33,413,363 23,570,402
Non-controlling interest 2,141,098 1,459,381
Total equity (unlabelled subtotal) 35,554,461 25,029,783
Borrowings 2,386,520 3,513,145
Lease liabilities 139,437 208,610
Retirement benefit obligation 1,636,926 895,765
Deferred income6 223,324 –7
Deferred tax 3,752,513 1,061,698
Non-current liabilities (unlabelled subtotal) 8,138,720 5,679,218
Trade and other payables 8,659,624 10,114,593
Borrowings 6,916,159 10,474,953
Deferred income6 213,826 –8
Current tax payable 5,792,599 912,180
Current liabilities (unlabelled subtotal) 21,582,208 21,501,726
Total Liabilities 29,720,928 27,180,944
Total Equity and Liabilities 65,275,389 52,210,727
  1. Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_assets.
  2. Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_liabilities.
  3. Printed “-”, read as nil: subtotal_arithmetic: bs.current_liabilities.
Notes and alternative reported figures (5)
  1. “Investments in subsidiaries” is an issuer-specific line, not mapped to a shared definition: Note 38 (Company line; Group prints dashes).
  2. “Investment in financial assets”: mapping to a shared definition is uncertain. Printed 'Investment in financial assets' (note 18: equity instruments at FVTOCI).
  3. “Finance lease receivables” is an issuer-specific line, not mapped to a shared definition: Note 41: non-current.
  4. “Reserves”: mapping to a shared definition is uncertain. Printed 'Reserves' (note 28.1: revaluation, fair value, translation and other reserves).
  5. “Deferred income” is an issuer-specific line, not mapped to a shared definition: Note 24.

Cash flow

Cash flow, NGN thousands. Columns: FY to 30 Sep 2025 — audited financial statements (signed / final), as reported for the year; FY to 30 Sep 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 30 Sep 2025Audited financial statementsreported for the yearFY to 30 Sep 2024Audited financial statementscomparative in FY to 30 Sep 2025 filing
Cash generated from operations 16,515,569 6,096,715
Tax paid (1,002,670) (2,541,001)
Benefit paid1 (51,909) (27,496)
Contribution to the fund2 (230,940) (230,940)
Net cash from operating activities 15,230,052 3,297,278
Purchase of property, plant and equipment (1,072,578) (462,434)
Proceed from disposal of property, plant and equipment 13,630 6,797
Purchase of other intangible assets (1,700) (82,304)
Finance lease payment3 (91,801) (83,006)
Finance lease receipts4 57,012 51,865
Interest Income5 10,910 866,562
Net cash from investing activities (1,084,527) 297,480
Proceeds from borrowings 7,630,833 12,507,040
Repayment of borrowings (17,499,933) (28,603,428)
Effect of deferred income6 (604,769) –7
Lease liabilities8 (91,252) –7
Dividends paid (1,657,510) (2,245,991)
Statute barred dividend received ( Note 26.4 .1)9 –7 51,869
Net cash from financing activities (12,222,631) (18,290,510)
Total movement for cash & cash equivalent for the year 1,922,894 (14,695,752)
Cash at the beginning of the yearyear 7,110,133 21,833,668
Effect of exchange rate movement on cash balances (15,972) (27,783)
Cash and cash equivalent at the end of the year 9,017,055 7,110,133
  1. Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_financing.
Notes and alternative reported figures (8)
  1. “Benefit paid” is an issuer-specific line, not mapped to a shared definition: Operating activities (note 26): retirement benefits paid.
  2. “Contribution to the fund” is an issuer-specific line, not mapped to a shared definition: Operating activities (note 26).
  3. “Finance lease payment” is an issuer-specific line, not mapped to a shared definition: Investing activities (note 41).
  4. “Finance lease receipts” is an issuer-specific line, not mapped to a shared definition: Investing activities (note 41).
  5. “Interest Income”: mapping to a shared definition is uncertain. Printed 'Interest Income' in investing activities (equal to finance income, note 12).
  6. “Effect of deferred income” is an issuer-specific line, not mapped to a shared definition: Financing activities.
  7. “Lease liabilities”: mapping to a shared definition is uncertain. Printed 'Lease liabilities' under financing activities (note 43); 2024 prints a dash.
  8. “Statute barred dividend received ( Note 26.4 .1)” is an issuer-specific line, not mapped to a shared definition: Financing activities (note 26.4.1).

Per share and shares

Per share and shares. Columns: FY to 30 Sep 2025 — audited financial statements (signed / final), as reported for the year; FY to 30 Sep 2024 — audited financial statements (signed / final), comparative reported in the audited financial statements for 2025.
Line (as printed) FY to 30 Sep 2025Audited financial statementsreported for the yearFY to 30 Sep 2024Audited financial statementscomparative in FY to 30 Sep 2025 filing
Earnings / (loss) per share (per share)3 10.80001 0.29002
Profit / (loss) attributable to shareholders (NGN thousands)4 13,511,380 359,704
  1. Printed as 1,080.00 kobo; value converted to NGN at 100 kobo = 1 NGN.
  2. Printed as 29.00 kobo; value converted to NGN at 100 kobo = 1 NGN.
Notes and alternative reported figures (2)
  1. Earnings / (loss) per share: printed as “Basic and diluted earnings/(loss) per share (kobo)”.
  2. Profit / (loss) attributable to shareholders: printed as “Owners of the parent”.

Segments

Segment data not yet collected for this company in the pilot.

Dividends

Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.

Dividend events, the issuer's wording, and amounts as printed
Year endedEventWording as printedAmountUnitSource
30 Sep 2025 Dividends paid (cash flow statement) Dividends paid (1,657,510) NGN thousands Audited financial statements, p60
30 Sep 2024 Dividends paid (cash flow statement) Dividends paid (2,245,991) NGN thousands Audited financial statements, p60

Sources

Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.

  • Vitafoam Nigeria Plc Consolidated and Separate Financial Statements for the year ended 30 September 2025

    Year ended 30 September 2025 · Audited financial statements · signed / final

    Audit: PricewaterhouseCoopers (Chartered Accountants), Lagos, unmodified opinion · signed

    Auditor's sign-off: Edafe Erhie, engagement partner, for PricewaterhouseCoopers

    Final status: Independent auditor's report to the members of Vitafoam Nigeria Plc by PricewaterhouseCoopers (engagement partner Edafe Erhie, FRC/2013/PRO/ICAN/004/00000001143), unmodified opinion with no key audit matters (p52), hand-signed with an ICAN seal and dated 24 December 2025 (p55, page image). Statements approved by the board on 18 December 2025 and signed by the Group Managing Director/CEO and the Head, Finance and Accounts (p57, scanned page image).

    Document date
    24 Dec 2025
    Auditor's report
    24 Dec 2025
    Board approval
    18 Dec 2025
    Retrieved by us
    8 Oct 2026 (not a publication date)
    Used for
    statement columns FY to 30 Sep 2025, FY to 30 Sep 2024
    Basis
    consolidated statements · NGN thousands (printed “N '000”)
    • Earnings per share printed in kobo (1,080.00; 2024: 29.00, p56; diluted printed identically) is stored in naira (÷100) with the printed figure and unit kept.
    Technical details
    File
    128 pages, with a text layer
    SHA-256
    6a1151b0b297dcbbf06798609b34664a696e8701e7138639e5d38c4042904af7
    Entity as printed
    Vitafoam Nigeria Plc ("the company") and its subsidiaries (together "the group")
    Note
    The statement of financial position (PDF p57, printed 55) and a few narrative pages are scanned images without a text layer; p57 is read from Apple Vision OCR of the render. OCR drops the Group dashes (investment property, investments in subsidiaries, 2024 deferred income) and shifts some cells into neighbouring rows (right-of-use assets, deferred tax asset note '25.', current tax payable 2024 912,180 read into the deferred income row); those cells were read on the render (dashes / image_values, visual_only). Every Group cell on p57 was compared with the render. All subtotals add.
    Exchange copy
    retrieved 2026-10-08T17:52:34Z

Data notes

No figure-level notes beyond those in the tables.

Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text; matched to OCR text and compared cell by cell with the page image; read from the page image) (9 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.

Download

Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.

· Company methodology and coverage